Search

Avirup Bose

from New York, NY
Age ~42
Get Report
Connected to:
Aloke Bose, 76Amelia L Bose, 87Amit K Bose, 65Amitava Bose, 71Anthony L Bose, 46Anuradha Bose, 54Arun Bose, 38Balogun Bose, 50Biren K Bose, 67Bishwajeet T Bose, 61

Avirup Bose Phones & Addresses

  • 330 W 58Th St, New York, NY 10019 (212) 767-1589
  • 330 W 58Th St APT 8A, New York, NY 10019 (212) 582-3682
  • Cambridge, MA

Education

School / High School: Harvard Law School

Ranks

Licence: New York - Due to reregister within 30 days of birthday Date: 2011

Professional Records

Lawyers & Attorneys

Avirup Bose Photo 1

Avirup Bose - Lawyer

View page
Address:
Trilegal
(997) 179-7333 (Office)
Licenses:
New York - Due to reregister within 30 days of birthday 2011
Education:
Harvard Law School

Resumes

Resumes

Avirup Bose Photo 2

Director, Business Development And Licensing

View page
Location:
Cambridge, MA
Industry:
Pharmaceuticals
Work:
Novartis Institutes For Biomedical Research (Nibr)
Director, Business Development and Licensing
Novartis Institutes For Biomedical Research (Nibr) Feb 2017 - Nov 2017
Director Portfolio Management
Novartis Institutes For Biomedical Research (Nibr) Aug 2015 - Jan 2017
Associate Director of Portfolio Management
Novartis Institutes For Biomedical Research (Nibr) Apr 2014 - Jul 2015
Senior Investigator I
Novartis Mar 2010 - Mar 2014
Investigator Iii
Education:
University of Nebraska - Lincoln 1992 - 1997
Doctorates, Doctor of Philosophy, Biochemistry, Chemistry Techno India College of Technology
Skills:
Drug Discovery
Biochemistry
Drug Development
Cell
Pharmaceutical Industry
Molecular Biology
Life Sciences
Cell Biology
Pharmacology
Western Blotting
Assay Development
In Vitro
Chemistry
Diabetes
Lifesciences
Clinical Research
Lead Change
In Vivo
Avirup Bose Photo 3

Avirup Bose

View page
Location:
Cambridge, MA
Industry:
Legal Services
Avirup Bose Photo 4

Avirup Bose

View page
Location:
Greater Boston Area
Industry:
Legal Services
Avirup Bose Photo 5

Avirup Bose

View page
Location:
Greater Boston Area
Industry:
Legal Services

Publications

Us Patents

Method Of Treatment

View page
US Patent:
20100016387, Jan 21, 2010
Filed:
Dec 10, 2007
Appl. No.:
12/518551
Inventors:
Avirup Bose - Marlborough MA, US
Thomas Edward Hughes - Concord MA, US
International Classification:
A61K 31/428
A61K 31/423
A61K 31/4184
A61K 31/403
US Classification:
514367, 514375, 514394, 514417
Abstract:
Method of preventing or treating myocardial ischemia by inhibiting DGAT1 enzyme with a DGAT1 inhibitor compound.

Combination Treatment Of Liver Diseases Using Integrin Inhibitors

View page
US Patent:
20230060422, Mar 2, 2023
Filed:
Dec 18, 2020
Appl. No.:
17/786491
Inventors:
- Basel, CH
- South San Francisco, US
Avirup BOSE - Marlborough MA, US
Jacob CHA - South San Francisco CA, US
Nicole COOPER - Oakland CA, US
Darren FINKELSTEIN - South San Francisco CA, US
Linda GREENBAUM - Florham Park NJ, US
Johannes HULL - San Francisco CA, US
Susan Caroline KIRKLAND - Surrey, GB
Katerina LEFTHERIS - San Mateo CA, US
Maureen REILLY - Burlingame CA, US
Peter TARSA - Marshfield MA, US
Chinweike UKOMADU - Chestnut Hill MA, US
International Classification:
A61K 31/4162
A61K 31/4375
A61K 31/7048
A61K 45/06
A61P 1/16
Abstract:
The invention provides a pharmaceutical combination including an αvβintegrin inhibitor and at least one additional therapeutic agent for preventing, delaying or treating liver diseases or disorders. The additional therapeutic agent may be an SGLT1/2 inhibitor, among a diverse selection of agents. For example, the pharmaceutical combination includes (S)-2-(4-methyltetrahydro-2H-pyran-4-carboxamido)-9-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl) nonanoic acid (Compound 1) and at least one additional therapeutic agent.

Combination Treatment Of Liver Diseases Using Integrin Inhibitors

View page
US Patent:
20230055657, Feb 23, 2023
Filed:
Dec 18, 2020
Appl. No.:
17/786499
Inventors:
- Basel, CH
- South San Francisco CA, US
Avirup BOSE - Marlborough MA, US
Jacob CHA - South San Francisco CA, US
Nicole COOPER - Oakland CA, US
Darren FINKELSTEIN - South San Francisco CA, US
Linda GREENBAUM - Florham Park NJ, US
Johannes HULL - San Francisco CA, US
Susan Caroline KIRKLAND - Surrey, GB
Katerina LEFTHERIS - San Mateo CA, US
Maureen REILLY - Burlingame CA, US
Peter TARSA - Marshfield MA, US
Chinweike UKOMADU - Chestnut Hill MA, US
International Classification:
A61K 31/46
A61K 31/4353
A61P 1/16
Abstract:
The invention provides a pharmaceutical combination including an αvβ1 integrin inhibitor and at least one additional therapeutic agent for preventing, delaying or treating liver diseases or disorders. The at least one additional therapeutic agent may be a farnesoid X receptor (FXR) agonist. For example, the pharmaceutical combination includes (S)-2-(4-methyltetrahydro-2H-pyran-4-carboxamido)-9-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)nonanoic acid (Compound 1) and 2-[3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1, 3-ben-zothiazole-6-carboxylic acid (tropifexor).

Novel Fatty Acids And Their Use In Conjugation To Biomolecules

View page
US Patent:
20210000964, Jan 7, 2021
Filed:
Jun 1, 2020
Appl. No.:
16/889201
Inventors:
- Basel, CH
Avirup BOSE - Marlborough MA, US
Alexandra Marshall BRUCE - Cambridge MA, US
Alokesh DUTTAROY - Marlborough MA, US
Chikwendu IBEBUNJO - Newton MA, US
Aaron KANTER - Somerville MA, US
Louise Clare KIRMAN - Swampscott MA, US
Changgang LOU - Somerville MA, US
Aimee Richardson USERA - Winchester MA, US
Ken YAMADA - Brookline MA, US
Jun YUAN - Boston MA, US
Frederic ZECRI - Brookline MA, US
International Classification:
A61K 47/54
A61K 38/095
A61K 38/08
A61K 38/16
A61K 38/17
A61K 38/18
A61K 38/22
A61K 45/06
C07C 55/02
C07C 55/22
C07C 57/02
C07C 57/18
C07C 59/245
C12N 15/113
Abstract:
The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3:

Novel Fatty Acids And Their Use In Conjugation To Biomolecules

View page
US Patent:
20180326079, Nov 15, 2018
Filed:
May 21, 2018
Appl. No.:
15/985060
Inventors:
- Basel, CH
Avirup BOSE - Marlborough MA, US
Alexandra Marshall BRUCE - Cambridge MA, US
Alokesh DUTTAROY - Marlborough MA, US
Chikwendu IBEBUNJO - Newton MA, US
Aaron KANTER - Somerville MA, US
Louise Clare KIRMAN - Swampscott MA, US
Changgang LOU - Somerville MA, US
Aimee Richardson USERA - Winchester MA, US
Ken YAMADA - Brookline MA, US
Jun YUAN - Boston MA, US
Frederic ZECRI - Brookline MA, US
International Classification:
A61K 47/54
C07C 55/02
A61K 38/08
C12N 15/113
C07C 59/245
C07C 57/18
C07C 57/02
C07C 55/22
A61K 45/06
A61K 38/22
A61K 38/18
A61K 38/17
A61K 38/16
Abstract:
The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3:

Methods Of Treating Diabetes And Related Disorders

View page
US Patent:
20160235810, Aug 18, 2016
Filed:
Oct 16, 2014
Appl. No.:
15/029689
Inventors:
Avirup BOSE - Cambridge MA, US
Alokesh DUTTAROY - Cambridge MA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 38/17
Abstract:
The invention relates to methods of treating metabolic conditions, including type 2 diabetes mellitus, by administering prolactin-inducible protein (PIP) or fusion proteins, analogs or variants of PIP with altered or truncated PIP sequence, site-specific mutants, or chemically modified mutants including pharmaceutical properties comprising the same.

Novel Fatty Acids And Their Use In Conjugation To Biomolecules

View page
US Patent:
20160030585, Feb 4, 2016
Filed:
Jun 12, 2015
Appl. No.:
14/738272
Inventors:
David Weninger BARNES - Waban MA, US
Ken YAMADA - Brookline MA, US
Chikwendu IBEBUNJO - Newton MA, US
Alokesh DUTTAROY - Marlborough MA, US
Louis Clare KIRMAN - Swampscott MA, US
Alexandra Marshall BRUCE - Cambridge MA, US
Aimee Richardson USERA - Winchester MA, US
Frederic ZECRI - Brookline MA, US
Jun YUAN - Boston MA, US
Changgang LOU - Portage MI, US
Aaron KANTER - Somerville MA, US
Avirup BOSE - Marlborough MA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 47/48
A61K 45/06
C07C 55/22
C07C 59/245
C07C 57/02
A61K 38/22
C07C 55/02
A61K 38/17
C12N 15/113
A61K 38/16
A61K 38/08
A61K 38/18
C07C 57/18
Abstract:
The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3:
Control profile
Avirup Bose from New York, NY, age ~42 Get Report